ClinicalTrials.gov
public full text
Public Domain
Assessing Ocular Surface Changes After Changing Glaucoma Medications
Hypothesis: Changing to Travatan Z therapy increases the tear film break up time of subjects on Xalatan therapy presenting with ocular surface disease.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study on Safety and Performance of an Artificial Tear in Dry Eye Treatment in Subjects With Ocular Surface Inflammation#1140157
- Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye Disease#1086571
- Efficacy of Diacerein on Ocular Surface Disease in Degenerative Arthritis Patients#873610
- RMP-A03 Ocular Suspension in Patients With Pterygium#828904
- Modified Intraocular Lens to Reduce Eye Inflammation After Cataract Surgery in Uveitis Patients#864484
Record · ID 1073096
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive